Rouzioux C - Search Results

1

A high HIV DNA level in PBMCs at antiretroviral treatment interruption predicts a shorter time to treatment resumption, independently of the CD4 nadir.

Piketty C, Weiss L, Assoumou L, Burgard M, Mélard A, Ragnaud JM, Bentata M, Girard PM, Rouzioux C, Costagliola D; ANRS 116 SALTO Study Group. Piketty C, et al. Among authors: rouzioux c. J Med Virol. 2010 Nov;82(11):1819-28. doi: 10.1002/jmv.21907. J Med Virol. 2010. PMID: 20872707 Clinical Trial.

2

LTR real-time PCR for HIV-1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01).

Avettand-Fènoël V, Chaix ML, Blanche S, Burgard M, Floch C, Toure K, Allemon MC, Warszawski J, Rouzioux C; French Pediatric Cohort Study ANRS-CO 01 Group. Avettand-Fènoël V, et al. Among authors: rouzioux c. J Med Virol. 2009 Feb;81(2):217-23. doi: 10.1002/jmv.21390. J Med Virol. 2009. PMID: 19107966

3

Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy.

Weiss L, Piketty C, Assoumou L, Didier C, Caccavelli L, Donkova-Petrini V, Levy Y, Girard PM, Burgard M, Viard JP, Rouzioux C, Costagliola D; ANRS 116 SALTO study group. Weiss L, et al. Among authors: rouzioux c. PLoS One. 2010 Jul 21;5(7):e11659. doi: 10.1371/journal.pone.0011659. PLoS One. 2010. PMID: 20657770 Free PMC article. Clinical Trial.

4

T-cell activation positively correlates with cell-associated HIV-DNA level in viremic patients with primary or chronic HIV-1 infection.

Weiss L, Chevalier MF, Assoumou L, Didier C, Girard PM, Piketty C, Costagliola D, Rouzioux C; ANRS 116 SALTO Study Group. Weiss L, et al. Among authors: rouzioux c. AIDS. 2014 Jul 17;28(11):1683-7. doi: 10.1097/QAD.0000000000000319. AIDS. 2014. PMID: 24841127

5

A low HIV-DNA level in peripheral blood mononuclear cells at antiretroviral treatment interruption predicts a higher probability of maintaining viral control.

Assoumou L, Weiss L, Piketty C, Burgard M, Melard A, Girard PM, Rouzioux C, Costagliola D; ANRS 116 SALTO study group. Assoumou L, et al. Among authors: rouzioux c. AIDS. 2015 Sep 24;29(15):2003-7. doi: 10.1097/QAD.0000000000000734. AIDS. 2015. PMID: 26355572 Clinical Trial.

6

Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts.

Rouzioux C, Hubert JB, Burgard M, Deveau C, Goujard C, Bary M, Séréni D, Viard JP, Delfraissy JF, Meyer L; SEROCO Cohort Study Group. Rouzioux C, et al. J Infect Dis. 2005 Jul 1;192(1):46-55. doi: 10.1086/430610. Epub 2005 May 31. J Infect Dis. 2005. PMID: 15942893

7

Interruption of antiretroviral therapy initiated during primary HIV-1 infection: impact of a therapeutic vaccination strategy combined with interleukin (IL)-2 compared with IL-2 alone in the ANRS 095 Randomized Study.

Goujard C, Marcellin F, Hendel-Chavez H, Burgard M, Meiffrédy V, Venet A, Rouzioux C, Taoufik Y, El Habib R, Beumont-Mauviel M, Aboulker JP, Lévy Y, Delfraissy JF; PRIMOVAC-ANRS 095 Study Group. Goujard C, et al. Among authors: rouzioux c. AIDS Res Hum Retroviruses. 2007 Sep;23(9):1105-13. doi: 10.1089/aid.2007.0047. AIDS Res Hum Retroviruses. 2007. PMID: 17919105 Clinical Trial.

8

Factors influencing peripheral blood mononuclear cell-associated HIV-1 DNA level after long-term suppressive antiretroviral therapy in 236 patients.

Burgard M, Boufassa F, Viard JP, Garrigue I, Ruffault A, Izopet J, Vabret A, Descamps D, Colson P, Seigneurin JM, Rouzioux C; ANRS AC11 Working Group. Burgard M, et al. Among authors: rouzioux c. AIDS. 2009 Oct 23;23(16):2165-71. doi: 10.1097/QAD.0b013e32833032d4. AIDS. 2009. PMID: 19657270

9

Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy.

Guihot A, Tubiana R, Breton G, Marcelin AG, Samri A, Assoumou L, Goncalves E, Bricaire F, Costagliola D, Calvez V, Rouzioux C, Autran B, Katlama C, Carcelain G; ALT-ANRS CO-15 study group; DECAMUNE study group. Guihot A, et al. Among authors: rouzioux c. AIDS. 2010 Feb 20;24(4):614-7. doi: 10.1097/QAD.0b013e32833556f3. AIDS. 2010. PMID: 19952710

10

Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIV.

Lévy Y, Thiébaut R, Gougeon ML, Molina JM, Weiss L, Girard PM, Venet A, Morlat P, Poirier B, Lascaux AS, Boucherie C, Sereni D, Rouzioux C, Viard JP, Lane C, Delfraissy JF, Sereti I, Chêne G; ILIADE Study Group. Lévy Y, et al. Among authors: rouzioux c. AIDS. 2012 Mar 27;26(6):711-20. doi: 10.1097/QAD.0b013e3283519214. AIDS. 2012. PMID: 22301410 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

511 results

Search Page

Filters